Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
NCT Number: NCT03057327
The proposed study is a pilot and feasibility study designed to develop materials to enhance early detection of melanomas among women at risk to develop melanoma due to indoor tanning, having a family history of melanoma or a personal history of melanoma.
The hypothesis of this study is that women, who are engaged in health promotion by having mammograms, will be able to assess the personal relevance of skin self-examination (SSE), be interested in learning about SSE and able to implement SSE while they are partially disrobed in the privacy of the changing room in the mammogram facility.
Looking for future studies?
Notify Me18 year–70 year
Female
Interventional
Not applicable
Chicago, Illinois, 60611, United States
After patients complete the mammogram, they return to the changing room and put on their clothing. After exiting the changing room in the Lynn Sage Comprehensive Breast Center of Northwestern Medicine/Prentice Women's Hospital and as they are preparing to leave, a research assistant (RA) will screen potential participants to acquire a randomly selected convenience sample of eligible participants (n=200). The first 100 eligible subjects will be asked if they regularly check their moles for concerning features. If the response is yes, then they will be asked if they have found concerning moles and what they did next. Verbal assent will be obtained.
Then the SSE materials will be placed into the changing rooms and the next 100 eligible subjects will be surveyed. The women, who found the information relevant, will be asked if they chose to check their skin while in the changing room. The skin location checked and use of the SSE kit will be ascertained. Women will be asked if they think they have a concerning mole. If the woman does not find a concerning mole, she will be asked if she intends to check her skin again. In addition, she will be asked if she intends to check the skin of family members. Women will be invited to take a brochure to help implement SSE.
The screening questions are as follows:
___Yes __ No
___Yes __ No
___Yes __ No If yes, which way do you prefer to be contacted?
Phone _________________________(Number) Email _________________________ (Address)
___Yes __ No
___Yes __ No If yes, which way do you prefer to be contacted?
Phone _________________________(Number) Email _________________________ (Address)
The RA will record the responses. Women who checked their skin ,either today or in about 2 weeks, will be invited to participate in a survey about skin location(s) checked, use of the SSE kit, and their decision about the spot on the skin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Following development of a draft of a brochure, women will agree to review a draft and provide comment during a 5 minute interview
Women 18 years of age and older who respond positively to the three screening questions:
Noticed information about checking your skin for melanoma. Thought this information was applicable to them. Checked skin or will consider checking skin in the future.
Exclusion criteria
Intervention:
Prior to placing the intervention materials into the changing rooms, 100 eligible subjects will be asked if they regularly check their moles for concerning features. If the response is yes, then they will be asked if they have found concerning moles and what they did next.
Time frame: 4 weeks
Checked Moles
Time frame: 2 weeks
Found Concerning mole
Time frame: 2 weeks
Made appointment to see a doctor about the mole
Northwestern University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07670403
Basal Cell Carcinoma of Skin, Behavior
Chengdu, Sichuan, China
View Trial DetailsNCT07429123
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Majadahonda, Madrid, Spain
View Trial DetailsNCT07428954
Acne, Acne Vulgaris
Bilbao, Basque Country, Spain
View Trial DetailsNCT07428941
Actinic Keratoses, Bacterial Infections
Bilbao, Basque Country, Spain
View Trial Details